The DigniCap Scalp Cooling System and its use in the treatment of chemotherapy-induced alopecia
| Autor: | Laura J. Esserman, Michelle E. Melisko, Mollie M Mustoe, Hope S. Rugo, Carmen M Lee |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
Cancer Research
medicine.medical_specialty Side effect medicine.medical_treatment Antineoplastic Agents 03 medical and health sciences 0302 clinical medicine Quality of life Hypothermia Induced medicine Humans 030212 general & internal medicine Chemotherapy Scalp integumentary system business.industry Cancer Alopecia General Medicine Hair follicle medicine.disease Surgery medicine.anatomical_structure Hair loss Oncology 030220 oncology & carcinogenesis Scalp cooling business |
| Zdroj: | Future oncology (London, England). 14(24) |
| ISSN: | 1744-8301 |
| Popis: | Chemotherapy-induced alopecia remains an emotionally traumatic side effect for cancer patients that impacts the quality of life, may be protracted in duration and may influence treatment decisions. Scalp cooling has been shown to be effective in preventing chemotherapy-induced alopecia. The DigniCap Scalp Cooling System is designed to prevent hair loss by cooling the scalp to reduce the impact of chemotherapy on hair follicle cells. Recent studies have shown the safety, efficacy and low-grade toxicity of the DigniCap System with a 66.3% success rate in hair preservation (n = 106) relative to 0% in a nonrandomized control group according to a prospective pivotal study. Data also support improved quality of life in several domains. Two scalp cooling devices including the DigniCap are now US FDA cleared and can be offered as a part of standard of care. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|